These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


47 related items for PubMed ID: 2848277

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L, Arru M, Ronzoni M, Salvioni M, Villa E, Ferla G.
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [Abstract] [Full Text] [Related]

  • 3. [Complication due to arterial infusion chemotherapy for liver metastasis from colorectal cancer].
    Tsuji Y, Hamada H, Katsuki Y, Hashimoto M, Tomita I, Kon H, Sasaki R, Kawata S, Yasuda T.
    Gan To Kagaku Ryoho; 1997 Sep; 24(12):1838-42. PubMed ID: 9382546
    [Abstract] [Full Text] [Related]

  • 4. [Complications of intra-arterial infusion chemotherapy in patients with colorectal cancer with liver metastasis, with special reference to IA-5-FU induced sclerosing cholangitis].
    Sawada T, Hojo K, Moriya Y.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):3087-91. PubMed ID: 2506836
    [Abstract] [Full Text] [Related]

  • 5. Sclerosing cholangitis from intraarterial floxuridine.
    Dikengil A, Siskind BN, Morse SS, Swedlund A, Bober-Sorcinelli KE, Burrell MI.
    J Clin Gastroenterol; 1986 Dec; 8(6):690-3. PubMed ID: 2949003
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.
    Kemeny N, Eid A, Stockman J, Gonen M, Schwartz L, Tetzlaff E, Paty P.
    J Surg Oncol; 2005 Aug 01; 91(2):97-101. PubMed ID: 16028279
    [Abstract] [Full Text] [Related]

  • 8. [Adjuvant regional chemotherapy after resection of liver metastases of primary colorectal tumors].
    Lorenz M, Hottenrott C, Encke A.
    Zentralbl Chir; 1993 Aug 01; 118(5):279-89. PubMed ID: 8322538
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.
    Hohn DC, Stagg RJ, Friedman MA, Hannigan JF, Rayner A, Ignoffo RJ, Acord P, Lewis BJ.
    J Clin Oncol; 1989 Nov 01; 7(11):1646-54. PubMed ID: 2530317
    [Abstract] [Full Text] [Related]

  • 10. Regional hepatic arterial infusion of degradable starch microspheres increases fluorodeoxyuridine (FUdR) tumor uptake.
    Thom AK, Sigurdson ER, Bitar M, Daly JM.
    Surgery; 1989 Mar 01; 105(3):383-92. PubMed ID: 2522247
    [Abstract] [Full Text] [Related]

  • 11. Improved hepatic toxicity profile of portal vein adjuvant hepatic infusional chemotherapy.
    Faynsod M, Wagman LD, Longmate J, Carroll M, Leong LA.
    J Clin Oncol; 2005 Aug 01; 23(22):4876-80. PubMed ID: 16009960
    [Abstract] [Full Text] [Related]

  • 12. [Sclerosing cholangitis after chemotherapy by continuous hepatic intra-arterial infusion of fluorodeoxyuridine].
    Bergmann JF, Rougier P, Liguory C, Zafrani ES, Métreau JM, Dhumeaux D.
    Gastroenterol Clin Biol; 1986 Feb 01; 10(2):177-9. PubMed ID: 2939001
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Biliary sclerosis associated with hepatic artery infusion of floxuridine.
    Bolton JS, Bowen JC.
    Surgery; 1986 Jan 01; 99(1):119-22. PubMed ID: 2934836
    [Abstract] [Full Text] [Related]

  • 15. [Intra-arterial (5-FU/FA and FUDR) versus systemic chemotherapy (5-FU/FA) of non-resectable colorectal liver metastases].
    Gassel HJ, Müller HH, Mattes P, Stieger R, Schramm H, Lorenz M.
    Langenbecks Arch Chir Suppl Kongressbd; 1998 Jan 01; 115():1458-60. PubMed ID: 9931911
    [Abstract] [Full Text] [Related]

  • 16. Percutaneous vs. surgical placement of hepatic artery indwelling catheters for regional chemotherapy.
    Aldrighetti L, Arru M, Angeli E, Venturini M, Salvioni M, Ronzoni M, Caterini R, Ferla G.
    Hepatogastroenterology; 2002 Jan 01; 49(44):513-7. PubMed ID: 11995485
    [Abstract] [Full Text] [Related]

  • 17. Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies.
    Ben-Josef E, Normolle D, Ensminger WD, Walker S, Tatro D, Ten Haken RK, Knol J, Dawson LA, Pan C, Lawrence TS.
    J Clin Oncol; 2005 Dec 01; 23(34):8739-47. PubMed ID: 16314634
    [Abstract] [Full Text] [Related]

  • 18. [Complications related to arterial infusion chemotherapy in patients with hepatic metastasis from colorectal cancer].
    Asami S, Kitahara K, Yamaguchi K, Ohashi Y, Miyashita K.
    Gan To Kagaku Ryoho; 2000 Oct 01; 27(12):1985-8. PubMed ID: 11086460
    [Abstract] [Full Text] [Related]

  • 19. Results of preoperative hepatic arterial infusion chemotherapy in patients undergoing liver resection for colorectal liver metastases.
    Pulitanò C, Arru M, Catena M, Guzzetti E, Vitali G, Ronzoni M, Venturini M, Villa E, Ferla G, Aldrighetti L.
    Ann Surg Oncol; 2008 Jun 01; 15(6):1661-9. PubMed ID: 18373123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 3.